U
LFCR icon

UBS’s Lifecore Biomedical LFCR Stock Holding History

UBS’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$179K Sell
14,620
-1,216
-8% -$15.2K ﹤0.01% 5303
2014
Q2 		$198K Buy
15,836
+4,912
+45% +$57.8K ﹤0.01% 5154
2014
Q1 		$122K Buy
10,924
+3,563
+48% +$39.1K ﹤0.01% 5756
2013
Q4 		$89K Buy
7,361
+3,861
+110% +$46.1K ﹤0.01% 6198
2013
Q3 		$43K Hold
3,500
– – ﹤0.01% 7057
2013
Q2 		$46K Buy
+3,500
New +$48.4K ﹤0.01% 6831

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

UBS's LFCR Position: Q3 2014 in Review

UBS reduced its Lifecore Biomedical (LFCR) stake by 7.7% in Q3 2014, selling an estimated $15.2K and leaving 14,620 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #5303.

UBS first reported a position in LFCR in Q2 2013 and has held it in 6 quarters since. The position peaked at $198K in Q2 2014. 107 funds tracked by Wall St. Rank hold LFCR as of Q3 2014.

  • UBS held 14,620 shares of Lifecore Biomedical worth $179K as of Q3 2014.
  • UBS sold 1,216 Lifecore Biomedical shares in Q3 2014, an estimated $15.2K.
  • Lifecore Biomedical made up ﹤0.01% of UBS's portfolio in Q3 2014, its #5303 holding.
  • UBS first reported a position in Lifecore Biomedical in Q2 2013 and has held it in 6 quarters since.
  • UBS's Lifecore Biomedical position peaked at $198K in Q2 2014.
  • 107 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.